iCAD Shares Climb After 4Q Sales Guidance Beats Expectations

Dow Jones

01-28

By Owen Tucker-Smith

iCAD shares jumped after the company issued fourth-quarter sales guidance ahead of Wall Street expectations.

Shares of the medical-device manufacturer were up 17% to $2.82 in Monday trading. The stock price is sitting above its 52-week high and has more than doubled over the past six months.

The company said it expects fourth-quarter revenue between $5.1 million and $5.3 million. Analysts surveyed by FactSet expected $4.5 million. The new guidance would represent a sales jump of between 8.5% and 12.8% from a year ago, when sales came in at $4.7 million.

The Nashua, N.H., company noted that it closed 106 deals in the fourth quarter, 19 of which were cloud deals with new and established customers.

iCAD, which develops AI-powered technology to detect breast cancer, said it would present at the 12th Annual MedTech, Digital Health, Life Science and Diagnostic Tools Conference taking place in Snowbird, Utah, in February.

Write to Owen Tucker-Smith at owen.tucker-smith@wsj.com

(END) Dow Jones Newswires

January 27, 2025 14:12 ET (19:12 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2506586089"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2506586089\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2506586089?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-01-28 03:12","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2506586089","market":"other","top_or_hot":-1,"title":"iCAD Shares Climb After 4Q Sales Guidance Beats Expectations","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Owen Tucker-Smith \n</p>\n<pre>\n \n</pre>\n<p>\n  iCAD shares jumped after the company issued fourth-quarter sales guidance ahead of Wall Street expectations. \n</p>\n<p>\n  Shares of the medical-device manufacturer were up 17% to $2.82 in Monday trading. The stock price is sitting above its 52-week high and has more than doubled over the past six months. \n</p>\n<p>\n  The company said it expects fourth-quarter revenue between $5.1 million and $5.3 million. Analysts surveyed by FactSet expected $4.5 million. The new guidance would represent a sales jump of between 8.5% and 12.8% from a year ago, when sales came in at $4.7 million. \n</p>\n<p>\n  The Nashua, N.H., company noted that it closed 106 deals in the fourth quarter, 19 of which were cloud deals with new and established customers. \n</p>\n<p>\n  iCAD, which develops AI-powered technology to detect breast cancer, said it would present at the 12th Annual MedTech, Digital Health, Life Science and Diagnostic Tools Conference taking place in Snowbird, Utah, in February. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Owen Tucker-Smith at owen.tucker-smith@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  January 27, 2025 14:12 ET (19:12 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>iCAD Shares Climb After 4Q Sales Guidance Beats Expectations</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\niCAD Shares Climb After 4Q Sales Guidance Beats Expectations\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-01-28 03:12</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Owen Tucker-Smith \n</p>\n<pre>\n \n</pre>\n<p>\n  iCAD shares jumped after the company issued fourth-quarter sales guidance ahead of Wall Street expectations. \n</p>\n<p>\n  Shares of the medical-device manufacturer were up 17% to $2.82 in Monday trading. The stock price is sitting above its 52-week high and has more than doubled over the past six months. \n</p>\n<p>\n  The company said it expects fourth-quarter revenue between $5.1 million and $5.3 million. Analysts surveyed by FactSet expected $4.5 million. The new guidance would represent a sales jump of between 8.5% and 12.8% from a year ago, when sales came in at $4.7 million. \n</p>\n<p>\n  The Nashua, N.H., company noted that it closed 106 deals in the fourth quarter, 19 of which were cloud deals with new and established customers. \n</p>\n<p>\n  iCAD, which develops AI-powered technology to detect breast cancer, said it would present at the 12th Annual MedTech, Digital Health, Life Science and Diagnostic Tools Conference taking place in Snowbird, Utah, in February. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Owen Tucker-Smith at owen.tucker-smith@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  January 27, 2025 14:12 ET (19:12 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":null,"symbol_name":null,"start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2506586089","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2506586089","pubTimestamp":1738005120,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"iCAD shares jumped after the company issued fourth-quarter sales guidance ahead of Wall Street expectations.Shares of the medical-device manufacturer were up 17% to $2.82 in Monday trading. The stock price is sitting above its 52-week high and has more than doubled over the past six months.The company said it expects fourth-quarter revenue between $5.1 million and $5.3 million. Analysts surveyed by FactSet expected $4.5 million. The new guidance would represent a sales jump of between 8.5% and 12.8% from a year ago, when sales came in at $4.7 million.The Nashua, N.H., company noted that it closed 106 deals in the fourth quarter, 19 of which were cloud deals with new and established customers.iCAD, which develops AI-powered technology to detect breast cancer, said it would present at the 12th Annual MedTech, Digital Health, Life Science and Diagnostic Tools Conference taking place in Snowbird, Utah, in February.","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{},"translate_title":"第四季度销售指引超出预期后iCAD股价上涨","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ICAD":0.9},"content_text":"By Owen Tucker-Smith \n\n\n \n\n\n  iCAD shares jumped after the company issued fourth-quarter sales guidance ahead of Wall Street expectations. \n\n\n  Shares of the medical-device manufacturer were up 17% to $2.82 in Monday trading. The stock price is sitting above its 52-week high and has more than doubled over the past six months. \n\n\n  The company said it expects fourth-quarter revenue between $5.1 million and $5.3 million. Analysts surveyed by FactSet expected $4.5 million. The new guidance would represent a sales jump of between 8.5% and 12.8% from a year ago, when sales came in at $4.7 million. \n\n\n  The Nashua, N.H., company noted that it closed 106 deals in the fourth quarter, 19 of which were cloud deals with new and established customers. \n\n\n  iCAD, which develops AI-powered technology to detect breast cancer, said it would present at the 12th Annual MedTech, Digital Health, Life Science and Diagnostic Tools Conference taking place in Snowbird, Utah, in February. \n\n\n \n\n\n  Write to Owen Tucker-Smith at owen.tucker-smith@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 27, 2025 14:12 ET (19:12 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1}}}